Daily non-political popular news in brief.
Engineered protein effective against Staphylococcus aureus toxin
05-21-2007 · EurekAlert!A research team led by the University of Illinois has developed a treatment for exposure to enterotoxin B, a noxious substance produced by the Staphylococcus aureus bacterium. The findings appear today in the online edition of Nature Medicine.
Read more »
Keywords: engineered, protein, effective, staphylococcus, aureus, toxin, staphylococcu, aureu
« Previous | Next »
Similar news on "Engineered protein effective against Staphylococcus aureus toxin":
- MRSA toxin acquitted: Study clears suspected key to severe bacterial illness
11-06-2006 · EurekAlert!
Researchers who thought they had identified the bacterial perpetrator of the often severe disease caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) had better keep looking: Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have exonerated a toxin widely thought to be the guilty party.
Similar news · Read more »
- Bacterial toxin closes gate on immune response, Penn researchers discover
02-13-2008 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine have demonstrated that a bacterial toxin from the common bacterium Staphylococcus aureus shuts down the control mechanism of the tunnel, called an ion channel, in immune cell membranes. Shutting down ion channels has long been known to suppress the immune response, and the bacteria may use the toxin to neutralize host defenses against bacteria.
Similar news · Read more »
- Developing kryptonite for Superbug
11-08-2007 · EurekAlert!
University of Idaho researchers are crossing academic and geographical bounds to develop more effective defenses against Staphylococcus aureus bacteria and other deadly pathogens. One of the goals of that effort is to create much faster and more accurate identification of strains resistant to the antibiotic methicillin, formally known as methicillin-resistant Staphylococcus aureus, or MRSA.
Similar news · Read more »
- Best treatment identified to reduce deadly Staph infections
12-03-2007 · EurekAlert!
One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.
Similar news · Read more »
- Staph vaccine shows promise in mouse study
10-30-2006 · EurekAlert!
By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. A report describing the University of Chicago study, funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, appears online this week in the Proceedings of the National Academy of Sciences.
Similar news · Read more »
- Studies highlight MRSA evolution and resilience
01-21-2008 · EurekAlert!
Community-associated methicillin-resistant Staphylococcus aureus infections are caused primarily by a single strain -- USA300 -- of an evolving bacterium that has spread with "extraordinary transmissibility" throughout the United States during the past five years, according to a new study led by National Institutes of Health scientists. CA-MRSA, an emerging public health concern, typically causes readily treatable soft-tissue infections such as boils, but also can lead to life-threatening conditions that are difficult to treat.
Similar news · Read more »
- Study on toxin that tainted spinach reveals treatment possibility
12-03-2007 · EurekAlert!
A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
Similar news · Read more »
- Sea cucumber protein used to inhibit development of malaria parasite
12-20-2007 · EurekAlert!
Scientists have genetically engineered a mosquito to release a sea-cucumber protein into its gut which impairs the development of malaria parasites, according to research out today (Dec. 21) in PLoS Pathogens. Researchers say this development is a step towards developing future methods of preventing the transmission of malaria.
Similar news · Read more »
- MRSA vaccine shows promise in mouse study
10-30-2006 · EurekAlert!
By combining the four bacterial surface proteins that generate the strongest immune response in mice, researchers at the University of Chicago have created a vaccine that significantly protects immunized animals from multiple disease-causing, drug-resistant strains of Staphylococcus aureus, the most common cause of hospital-acquired infections and a rapidly spreading source of community-associated illness.
Similar news · Read more »
- No high quality studies on reducing MRSA infection in nursing homes for elderly people
01-22-2008 · EurekAlert!
Nursing homes for older people provide environments where bacteria such as meticillin-resistant Staphylococcus aureus are likely to thrive. Despite this, there are no high quality studies that look specifically at means of reducing the risk of transmission and infection in this setting.
Similar news · Read more »
